Wells Fargo’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2
| Closed | -$8 | – | 7449 |
|
|
2024
Q1 | $8 | Hold |
2
| – | – | ﹤0.01% | 7336 |
|
|
2023
Q4 | $51 | Hold |
2
| – | – | ﹤0.01% | 6928 |
|
|
2023
Q3 | $48 | Hold |
2
| – | – | ﹤0.01% | 6929 |
|
|
2023
Q2 | $47 | Buy |
2
+1
| +100% | +$27 | ﹤0.01% | 7070 |
|
|
2023
Q1 | $30 | Buy |
+1
| New | +$104 | ﹤0.01% | 7263 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7185 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7353 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7476 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7798 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7796 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7510 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7429 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7364 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7014 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6892 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6813 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6786 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6441 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6606 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6562 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6565 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6565 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6518 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6462 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6446 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6493 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6443 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6334 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6320 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6417 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6407 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6440 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6508 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6356 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6404 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6340 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6278 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5639 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5919 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5836 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5696 |
|
Other funds holding TENX
TRCT
AF
Wells Fargo's TENX Position: Q2 2024 in Review
Wells Fargo sold out of Tenax Therapeutics (TENX) in Q2 2024, closing a stake of 2 shares — an estimated $8 sold.
Wells Fargo first reported a position in TENX in Q1 2023 and held it in 5 quarters. The position peaked at $51 in Q4 2023. 11 funds tracked by Wall St. Rank hold TENX as of Q2 2024.
- Wells Fargo reported no remaining Tenax Therapeutics position as of Q2 2024 after selling out during the quarter.
- Wells Fargo sold 2 Tenax Therapeutics shares in Q2 2024, an estimated $8.
- Wells Fargo first reported a position in Tenax Therapeutics in Q1 2023 and held it in 5 quarters.
- Wells Fargo's Tenax Therapeutics position peaked at $51 in Q4 2023.
- 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.